Hosted on MSN

How Does the PoNS Neurostimulation Device Help With Walking in MS?

For many people living with multiple sclerosis (MS), walking can become one of the most challenging daily tasks. As many as 3 in 4 people with MS have gait issues caused by factors like loss of muscle ...
Nasdaq

Helius Medical Technologies to Present PoNS® Device Study Results for Multiple Sclerosis at CMSC Annual Meeting 2025

Helius Medical Technologies, Inc. announced that it will present results from its new study on the Portable Neuromodulation Stimulator (PoNS®) at the upcoming Consortium of Multiple Sclerosis Centers ...
Seeking Alpha

University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

NEWTOWN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation ...
WIVB-TV

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

NEWTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...
Nasdaq

Helius Medical Technologies Announces Positive Results from PoNS Stroke Registrational Program Supporting Planned FDA Submission for Gait and Balance Therapy

Helius Medical Technologies, Inc. announced positive outcomes from its Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program (SRP), which supports a planned FDA submission for ...
Business Wire

Helius Medical Technologies Announces Clinical Device Readiness for PoNS™ 4.0

NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies, Inc. (CSE: HSM) (OTCQB: HSDT) (“Helius”) is pleased to announce that it has successfully released the ...
Monthly Prescribing Reference

Tongue-Delivered Neuromodulation Therapy Gets FDA Clearance for MS-Related Gait Deficit

PoNS is a portable, noninvasive, prescription-only device intended to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The Food and Drug ...
Seeking Alpha

Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685

NEWTOWN, Pa., April 17, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (HSDT) today announced it will exhibit at the American Academy of Neurology (AAN) Annual Meeting for the first time since ...
WHNT

Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait

NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99 th annual American ...
KHON2

PTAP Lowers the Cost of PoNS Therapy™ for Qualified Americans

NEWTOWN, Pa., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) today announced the extension of a program that puts the company’s Portable Neuromodulation Stimulator (PoNS ...
WRBL

Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device

-- Collaboration makes HealthTech Connex the exclusive provider of PoNS Therapy in the Vancouver area and will greatly strengthen Helius’s presence in the region -- NEWTOWN, Pa., March 22, 2023 (GLOBE ...